MetaADEDB 2.0 @ LMMD
Otitis Externa
(UMLS:C0029878)
Definition:
Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.
UMLS ID:
C0029878
MeSH ID:
D010032
Classification:
Name:
Otorhinolaryngologic Diseases
MeSH Tree Number(s):
C09.218.705.496
Synonym(s)
1.
Otitis Externa
2.
External Ear Inflammation
3.
External Otitis
4.
External ear inflammation
5.
Inflammation of External Auditory Canal
6.
Inflammation of ear canal
7.
Inflammation of the External Auditory Canal
8.
OE - Otitis externa
9.
OTITIS EXTERNA
10.
Otitis externa
11.
Otitis externa, NOS
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1AlendronateFAERS: 27
Canada Vigilance: 1		Canada Vigilance
US FAERS
2OndansetronFAERS: 15US FAERS
3rofecoxibFAERS: 14US FAERS
4IsotretinoinFAERS: 13US FAERS
5VemurafenibFAERS: 8US FAERS
6NuvaRingFAERS: 6US FAERS
7DexamethasoneFAERS: 5US FAERS
8SimvastatinFAERS: 5US FAERS
9Zoledronic AcidFAERS: 4US FAERS
104-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamideFAERS: 3US FAERS
11BosentanFAERS: 3US FAERS
12Imatinib MesylateFAERS: 3US FAERS
13TeriparatideFAERS: 3US FAERS
14VareniclineFAERS: 3US FAERS
15Erlotinib HydrochlorideFAERS: 2US FAERS
16FinasterideFAERS: 2US FAERS
17Fingolimod HydrochlorideFAERS: 2US FAERS
18Ruxolitinib phosphateFAERS: 2US FAERS
19Sildenafil CitrateFAERS: 2US FAERS
20Vardenafil DihydrochlorideFAERS: 2US FAERS
21VigabatrinFAERS: 2US FAERS
22ponatinibFAERS: 2US FAERS
234-hydroxybutyric acidFAERS: 1US FAERS
24AN2728FAERS: 1US FAERS
25AfatinibFAERS: 1US FAERS
26AmlodipineFAERS: 1US FAERS
27Carbamide PeroxideFAERS: 1US FAERS
28CiprodexFAERS: 1US FAERS
29ClozapineFAERS: 1US FAERS
30DeferasiroxFAERS: 1US FAERS
31Dimethyl FumarateFAERS: 1US FAERS
32Dioctyl Sulfosuccinic AcidFAERS: 1US FAERS
33EverolimusFAERS: 1US FAERS
34FentanylFAERS: 1US FAERS
35Fluticasone-Salmeterol Drug CombinationFAERS: 1US FAERS
36GabapentinFAERS: 1SIDER
US FAERS
37LoratadineFAERS: 1US FAERS
38MetoprololFAERS: 1US FAERS
39MoxifloxacinFAERS: 1US FAERS
40NorgestrelFAERS: 1US FAERS
41Ortho EvraFAERS: 1US FAERS
42OseltamivirFAERS: 1US FAERS
43PCI 32765FAERS: 1US FAERS
44PromethazineFAERS: 1US FAERS
45RivaroxabanFAERS: 1US FAERS
46SertralineFAERS: 1US FAERS
47Sitagliptin PhosphateFAERS: 1US FAERS
48Somatuline AutogelFAERS: 1US FAERS
49TacrolimusFAERS: 1SIDER
US FAERS
50ThyroxineFAERS: 1US FAERS
51Triamcinolone AcetonideFAERS: 1US FAERS
52lanreotideFAERS: 1
Canada Vigilance: 1		Canada Vigilance
US FAERS
53AcitretinSIDER
54AripiprazoleSIDER
55BexaroteneSIDER
56Carbenicillin6176609CTD
57CidofovirSIDER
58CiprofloxacinSIDER
59CitalopramSIDER
60DonepezilSIDER
61MemantineSIDER
62Minoxidil3390339CTD
63Mycophenolic AcidSIDER
64OxcarbazepineSIDER
65PantoprazoleSIDER
66ParoxetineSIDER
67PramipexoleSIDER
68PregabalinSIDER
69RabeprazoleSIDER
70RivastigmineSIDER
71SelegilineSIDER
72SumatriptanSIDER
73TiagabineSIDER
74TramadolSIDER
75Trimethoprim, Sulfamethoxazole Drug CombinationCanada Vigilance: 1Canada Vigilance
76Venlafaxine HydrochlorideSIDER
77VoriconazoleSIDER
78ZolpidemSIDER
79eprosartanSIDER
80rifapentineSIDER
81ropiniroleSIDER
82sibutramineSIDER
83triethanolamineCanada Vigilance: 9Canada Vigilance
84zopicloneSIDER
Similar ADE(s)
NameSemantic Similarity
1Otitis Media46.7%
2Labyrinthitis44.4%
3Otitis Media with Effusion34.4%
4Otosclerosis31%
5Tympanosclerosis31%
6Tympanic Membrane Perforation22%
7Otomycosis20.9%
8Congenital Microtia20.9%
9Ear Neoplasms20.5%
10Cochlear Diseases20%
11Vestibular Diseases20%
12Endolymphatic Hydrops20%
13Mastoiditis17.1%
14Petrositis17.1%
15Dysacusis15.1%
16Meniere Disease14.8%
17Vestibulocochlear Nerve Diseases13.6%
18Laryngeal Diseases12.8%
19Nose Diseases12.8%
20Pharyngeal Diseases12.8%
21Herpes Zoster Oticus12%
22Vestibular Neuronitis9.9%
23Hyperacusis9.8%
24Tinnitus9.8%
25Phonophobia9.8%
26Hearing Loss9.8%
27Pharyngeal Neoplasms8.3%
28Vertigo7.6%
29Deafness7.2%
30Hearing Loss, Sudden7.2%
31Hearing Loss, Bilateral7.2%
32Hearing Loss, High-Frequency7.2%
33Hearing Loss, Mixed Conductive-Sensorineural7.2%
34Hearing Loss, Unilateral7.2%
35Complete Hearing Loss7.2%
36Deaf Mutism7.2%
37Primary Ciliary Dyskinesia7.2%
38Granuloma, Lethal Midline7%
39Laryngeal Edema7%
40Nose Deformities, Acquired7%
41Laryngeal neoplasm6.9%
42Deglutition Disorders6.8%
43Nasopharyngeal Neoplasms5.7%
44Hypopharyngeal Neoplasms5.3%
45Hypopharyngeal Cancer5.3%
46Laryngitis5.3%
47Pharyngitis5.3%
48Rhinitis5.3%
49Vocal Cord Dysfunction5.3%
50Laryngostenosis5.2%
51Nasal Polyps5.2%
52Nose Neoplasms5.1%
53Paranasal Sinus Neoplasms5%
54Acoustic Neuroma4.9%
55Croup4.4%
56Nasopharyngitis4.4%
57Rhinitis, Vasomotor4.4%
58Auditory Perceptual Disorders4.2%
59Choanal Atresia4.2%
60Voice Disorders4.2%
61Voice Disturbance4.2%
62Laryngocele4.2%
63Epistaxis4.1%
64Tonsillar Neoplasms3.9%
65Maxillary Sinus Neoplasms3.6%
66Nasopharyngeal carcinoma3.6%
67Laryngomalacia3.4%
68Granuloma, Laryngeal3.4%
69Sinusitis3.4%
70Vocal Cord Paralysis3.4%
71Laryngospasm3.3%
72Tonsillitis3.3%
73Lemierre Syndrome2.8%
74Aphonia2.6%
75Retropharyngeal Abscess2.6%
76Dysphonia2.6%
77Rhinoscleroma2.5%
78Hay fever2%
79Rhinitis, Allergic, Perennial2%
80Peritonsillar Abscess1.9%
81Hoarseness1.9%
82Kartagener Syndrome1.5%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.